© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#mantle cell lymphoma
FDA Approves New CAR-T Therapy for Mantle Cell Lymphoma
Lymphocytes attacking cancer cells
Lymphoma Basics
A Mantle Cell Lymphoma Diary: Lindy Sledge

New COVID Vaccine May Better Protect Cancer Patients

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
Chimeric antigen receptor T-cell (CAR-T) therapy

CAR-T Immunotherapy Keeps Cancer in Remission for 10 Years

The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.

Now Approved

Here are latest arrivals approved by the Food and Drug Administration.
Tecartus (brexucabtagene autoleucel)

Tecartus

Experimental CAR-T Therapy Shows Promise for Mantle Cell Lymphoma

KTE-X19 led to durable remission in a majority of study participants.

Imbruvica

CAR-T for More Cancers

Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Chimeric antigen receptor T-cell (CAR-T) therapy

CAR-T Therapies Show Promise for More Blood Cancers

Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.

Brukinsa

Calquence (acalabrutinib)

Calquence

FDA Approves New Treatment for Mantle Cell Lymphoma

Clinical trials showed that 84% of patients saw tumor shrinkage with this therapy.

Revlimid

Velcade

After Three Cancer Diagnoses, Couple Exchanges Vows

“There’s nothing that we can’t face together. We’ll never walk alone.”
Tanya Siddiqi and Jeremy Abramson at ImmunoOnc18

Juno CAR-T Therapy Shows Durable Response for Non-Hodgkin Lymphoma

Safety profile suggests patients receiving the new immunotherapy may not need to be hospitalized.
Calquence (acalabrutinib)

FDA Approves New Treatment for Adults With Mantle Cell Lymphoma

The FDA granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma.
Advertisement

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.